Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma-Cell Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00871702
What this trial is testing

Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease

Who this might be right for
LeukemiaLymphoma, Non-HodgkinHodgkin Disease+2 more
Washington University School of Medicine 12
Testing effectiveness (Phase 2)Looking for participantsNCT06100237
What this trial is testing

Teclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-Oncology Study (the REVIVE Study)

Who this might be right for
Multiple Myeloma
Carl Ola Landgren, MD, PhD 50
Testing effectiveness (Phase 2)UnknownNCT04877275
What this trial is testing

ATG-010(Selinexor) in Combination With Chemotherapy in RRMM

Who this might be right for
Multiple Myeloma
Chunyan Sun, MD 50
Testing effectiveness (Phase 2)Study completedNCT00478075
What this trial is testing

Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 50
Large-scale testing (Phase 3)Study completedNCT00270101
What this trial is testing

The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma

Who this might be right for
AnemiaMultiple Myeloma
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 156
Testing effectiveness (Phase 2)Looking for participantsNCT06580002
What this trial is testing

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Who this might be right for
Breast CancerSarcomaGastric Cancer+19 more
University of California, Irvine 75
Testing effectiveness (Phase 2)Looking for participantsNCT07149857
What this trial is testing

Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 60
Large-scale testing (Phase 3)Study completedNCT03217812
What this trial is testing

VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Combination With VMP (D-VMP), in Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-Dose Therapy (Asia Pacific Region)

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 220
Not applicableLooking for participantsNCT06855121
What this trial is testing

The Norwegian Immunotherapy in Multiple Myeloma Study

Who this might be right for
Myeloma MultiplePlasma Cell LeukemiaAL Amyloidosis
St. Olavs Hospital 400
Not applicableStudy completedNCT04484714
What this trial is testing

Virtual Exercise for Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Alberta 31
Large-scale testing (Phase 3)Study completedNCT00103506
What this trial is testing

Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 646
Not applicableUnknownNCT04004338
What this trial is testing

Carfilzomib in Combination for the Treatment of RR MM

Who this might be right for
Multiple MyelomaRelapse Multiple MyelomaRefractory Multiple Myeloma
Black Sea Hematology Association 300
Not applicableLooking for participantsNCT00900198
What this trial is testing

Collection of Tissue Samples for Cancer Research

Who this might be right for
NeoplasmsLymphomasMultiple Myeloma+1 more
National Cancer Institute (NCI) 5,000
Not applicableStudy completedNCT02294487
What this trial is testing

Study of the Immune Response After Vaccination in Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaMyeloma, MultipleMyeloma-Multiple
Wake Forest University Health Sciences 19
Testing effectiveness (Phase 2)Looking for participantsNCT05469893
What this trial is testing

Immuno-PRISM (PRecision Intervention Smoldering Myeloma)

Who this might be right for
High-risk Smoldering Multiple MyelomaSmoldering Multiple MyelomaMultiple Myeloma
Irene Ghobrial, MD 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT03556332
What this trial is testing

Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 41
Not applicableNot Yet RecruitingNCT04702932
What this trial is testing

Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaWaldenstrom Macroglobulinemia
Assistance Publique - Hôpitaux de Paris 30
Testing effectiveness (Phase 2)Study completedNCT00002652
What this trial is testing

Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Arkansas
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07560449
What this trial is testing

QLS4131 Combination Therapy in Malignant Plasma Cell Neoplasms

Who this might be right for
Malignant Plasma Cell Neoplasms
Qilu Pharmaceutical Co., Ltd. 162
Early research (Phase 1)Study completedNCT00697684
What this trial is testing

Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeAcute Lymphocytic Leukemia+4 more
Beth Israel Deaconess Medical Center 29
Next Page